Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 235457 |
| Drug Identification Number | 02439387 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION |
| Packaging size | 10 mL |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-08-26 |
| Actual start date | |
| Estimated end date | 2024-10-30 |
| Actual end date | 2024-10-15 |
| Shortage status | Resolved |
| Updated date | 2024-10-17 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Ropivacaine Hydrochloride Injection, USP 5 mg/mL Ampoule 10 mL effective August 26, 2024, until October 30, 2024. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-10-17 | French | Compare |
| v6 | 2024-10-17 | English | Compare |
| v5 | 2024-09-11 | French | Compare |
| v4 | 2024-09-11 | English | Compare |
| v3 | 2024-08-27 | English | Compare |
| v2 | 2024-08-16 | French | Compare |
| v1 | 2024-08-16 | English | Compare |
Showing 1 to 7 of 7